Arqule Cash and ST Investments:
79.27M for Dec. 31, 2012Arqule Historical Cash and ST Investments Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 79.27M |
| Sept. 30, 2012 | 82.76M |
| June 30, 2012 | 75.09M |
| March 31, 2012 | 68.18M |
| Dec. 31, 2011 | 68.17M |
| Sept. 30, 2011 | 105.93M |
| June 30, 2011 | 84.09M |
| March 31, 2011 | 110.07M |
| Dec. 31, 2010 | 80.70M |
| Sept. 30, 2010 | 86.28M |
| June 30, 2010 | 109.38M |
| March 31, 2010 | 143.04M |
| Dec. 31, 2009 | 154.68M |
| Sept. 30, 2009 | 108.94M |
| June 30, 2009 | 117.37M |
| March 31, 2009 | 128.90M |
| Dec. 31, 2008 | 141.89M |
| Sept. 30, 2008 | 74.67M |
| June 30, 2008 | 41.19M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and short term investments are considered very liquid assets. For instance, if a company needs immediate liquidity, cash and short term investments can be be quickly used. Cash and short term investments are frequently used in liquidity ratios.
Learn More
ARQL Cash and ST Investments Benchmarks
| Companies | |
|---|---|
| Biodel | 34.28M |
| Agenus | 17.21M |
| Onyx Pharmaceuticals | 730.68M |
ARQL Cash and ST Investments Rankings
| Overall |
73rd percentile 2001 of 7593 |
| Sector |
65th percentile 221 of 650 in Healthcare |
| Industry |
66th percentile 79 of 237 in Biotechnology |
ARQL Cash and ST Investments Range, Past 5 Years
| Minimum | 41.19M | Jun 2008 |
| Maximum | 154.68M | Dec 2009 |
| Average | 97.93M |
